Advertisement

Seeking Another Cancer Perspective

Published on: 
CURE, Spring 2023, Volume 22, Issue 1

A new method of chemotherapy administration is being explored for certain solid cancers.

Chemotherapy has been used for decades to treat several types of cancer, but now researchers are looking into innovative ways to deliver this treatment in particular cancers, including appendiceal, ovarian, gastric and colon cancers.

Pressurized intraperitoneal aerosolized chemotherapy, or PIPAC, involves spraying chemotherapy directly onto the microscopic tumors that lie on the surface of the abdominal cavity. This approach may allow the treatment to go deeper into the tumor.

In this seasonal issue of CURE®, we speak to a patient who participated in a clinical trial assessing PIPAC for the treatment of her ovarian cancer. While in the trial, she was able to undergo more rounds of PIPAC compared with traditional deliveries of chemotherapy because she responded so well to it.

Another feature in this seasonal issue focuses on how training for a triathlon, for example, can not only prepare your body for a race but also potentially your mind when receiving a diagnosis of cancer.

We spoke with an Ironman competitor who received a diagnosis of stage 4 colorectal cancer just after completing a race. Although she was unable to fully train after undergoing surgery, she maintained movement throughout the rest of her treatments, which allowed her to keep her body and mind sharp. She no longer competes in Ironman competitions, but she uses swimming, running and biking to raise money and awareness for cancer.

On the topic of health and wellness, a doctor wrote a story about the importance of diet and healthy eating during one’s cancer journey. She describes what types of foods to focus on and what types of benefits they may provide patients.

Other topics addressed in this seasonal issue are seeing test results before an oncologist reviews them with a patient, creating art as a means of therapy at home, immunotherapy in lung cancer and triplet therapy for patients with multiple myeloma.

As always, we hope you find our stories inspirational and informative. Thank you for reading.

MIKE HENNESSY JR.

President & CEO

MJH LIFE SCIENCES®


For more news on cancer updates, research and education, don’t forget to subscribe to CURE®’s newsletters here.


Advertisement
Advertisement